https://doi.org/10.1186/s12885-020-07043-5
A
Aidong Lu
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
81
Papers
423
Citations
12
h-index
17
i10-index
Aidong Lu is an academic researcher from Peking University. The author has contributed to research in topics: Acute Lymphoblastic Leukemia research & Acute Myeloid Leukemia Research & Childhood Cancer Survivors' Quality of Life. The author has an h-index of 12, co-authored 69 publications.
Papers by this author
worksAllogeneic hematopoietic stem cell transplantation can improve the prognosis of high-risk pediatric t(8;21) acute myeloid leukemia in first remission based on MRD-guided treatment
2020 · BMC Cancer · 32 citations
Chimeric Antigens Receptor T Cell Therapy Improve the Prognosis of Pediatric Acute Lymphoblastic Leukemia With Persistent/Recurrent Minimal Residual Disease in First Complete Remission
2022 · Frontiers in Immunology · 11 citations
https://doi.org/10.3389/fimmu.2021.731435
Comparisons of Long-Term Survival and Safety of Haploidentical Hematopoietic Stem Cell Transplantation After CAR-T Cell Therapy or Chemotherapy in Pediatric Patients With First Relapse of B-Cell Acute Lymphoblastic Leukemia Based on MRD-Guided Treatment
2022 · Frontiers in Immunology · 11 citations
https://doi.org/10.3389/fimmu.2022.915590
Low EVI1 expression at diagnosis predicted poor outcomes in pediatric Ph-negative B cell precursor acute lymphoblastic leukemia patients
2021 · Pediatric Hematology and Oncology · 2 citations
https://doi.org/10.1080/08880018.2021.1939818
[Clinical Significance of Minimal Residual Disease in Pediatric Patients with <i>TCF3/PBX1</i><sup>+</sup> B-cell Acute Lymphoblastic Leukemia].
2023 · PubMed · 0 citations
https://doi.org/10.19746/j.cnki.issn.1009-2137.2023.05.008
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat